| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/15/2013 | US8557960 Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same |
| 10/15/2013 | US8557955 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 10/15/2013 | US8557780 Monomethylvaline compounds capable of conjugation to ligands |
| 10/15/2013 | US8557765 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 10/15/2013 | CA2598316C Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 10/10/2013 | WO2013151467A2 Method for producing a recombinant peptide and resultant peptide |
| 10/10/2013 | US20130267713 Hepatitis C Virus Inhibitors |
| 10/10/2013 | US20130267681 Chemical ligation by ring opening of oxo-thiomorpholines |
| 10/10/2013 | US20130267610 Novel lipid dipeptide and gel |
| 10/10/2013 | US20130267609 Novel lipid dipeptide and gel |
| 10/10/2013 | US20130267467 Serine protease inhibitors |
| 10/09/2013 | EP2647647A2 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 10/09/2013 | EP2647386A1 Lissencephaly therapeutic agent |
| 10/09/2013 | CN103347530A Therapeutic agent and preventive agent for diabetes |
| 10/09/2013 | CN102584941B Paddy rice Ustiloxin A extracting and purifying method |
| 10/08/2013 | US8552152 Compositions and methods for modulating dopamine neurotransmission |
| 10/08/2013 | US8552148 TNF-α antagonists containing IGFBP5 |
| 10/08/2013 | US8552146 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 10/08/2013 | US8552145 Vaccine for modulating between T1 and T2 immune responses |
| 10/08/2013 | US8552016 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/08/2013 | US8551493 Peptide with reduced dimer formation |
| 10/08/2013 | US8551492 Vaccine peptide combinations against cat allergy |
| 10/08/2013 | CA2570321C Inhibitors of iap |
| 10/03/2013 | US20130261066 Treatment of inflammatory bowel diseases using a tripeptide |
| 10/03/2013 | US20130261064 N-carboxyalkyl-auristatin and the use thereof |
| 10/03/2013 | US20130261052 Inhibition of memapsin 1 cleavage in the treatment of diabetes |
| 10/02/2013 | EP2644618A1 tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators |
| 10/02/2013 | CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof |
| 10/02/2013 | CN103333085A Preparation and separation method of neotame intermediate imine |
| 10/02/2013 | CN101429230B Refining method for Ganguertai |
| 10/01/2013 | US8546535 Lytic domain fusion constructs and methods of making and using same |
| 10/01/2013 | US8546531 Methods and reagents for preparing multifunctional probes |
| 10/01/2013 | US8546530 Process for the manufacture of persilylated peptides |
| 10/01/2013 | US8546528 Skin or hair binding peptides |
| 10/01/2013 | US8546526 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits |
| 10/01/2013 | US8546339 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase |
| 10/01/2013 | US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 10/01/2013 | CA2678967C Rna targeting compounds and methods for making and using same |
| 09/26/2013 | WO2013142229A1 Designing novel peptides for inducing fibronectin matrix assembly |
| 09/26/2013 | WO2013142088A1 Short antimicrobial lipopeptides |
| 09/26/2013 | WO2013140902A1 Dipeptide derivative, and amphipathic low-molecular-weight gelator comprising dipeptide derivative |
| 09/26/2013 | WO2013140388A1 Peptides for management of lactation |
| 09/26/2013 | US20130252907 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell |
| 09/26/2013 | US20130252906 Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin |
| 09/26/2013 | US20130252901 Peptide compound useful for inhibiting amyloid plaque formation |
| 09/26/2013 | US20130252878 Composition containing peptide ligand that bonds with cxcr2 for treating infective and inflammatory diseases |
| 09/25/2013 | EP2640737A1 Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 09/25/2013 | EP2640423A1 Lipoyl compounds and their use for treating ischemic injury |
| 09/25/2013 | CN103328496A Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/25/2013 | CN103319568A Non-protein amino acid antibacterial peptide and application for same |
| 09/25/2013 | CN103319567A Tripeptide compound and preparation method and applications thereof |
| 09/25/2013 | CN102477070B Oligopeptide with thrombus dissolving activities and preparation method and application thereof |
| 09/25/2013 | CN101914376B Peptidomimetic fluorescent ion probe and application thereof in metal ion detection |
| 09/25/2013 | CN101870719B Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof |
| 09/25/2013 | CN101724016B Peptide compound and preparation method and application thereof |
| 09/25/2013 | CN101421293B Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/24/2013 | US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention |
| 09/24/2013 | US8541579 Substituted diketopiperazines as oxytocin antagonists |
| 09/24/2013 | US8541568 Compositions and methods using siRNA molecules for treatment of gliomas |
| 09/24/2013 | US8541545 Stabilized melanocortin ligands |
| 09/24/2013 | US8541544 Molecular marker for cancer stem cell |
| 09/24/2013 | US8541543 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/24/2013 | CA2658491C Membrane-translocating peptides |
| 09/24/2013 | CA2557645C Caspase inhibitors and uses thereof |
| 09/19/2013 | WO2013138474A1 Compositions and methods for analyzing histidine phosphorylation |
| 09/19/2013 | WO2013137569A1 Tetrapeptide, and skin antiaging and anti-inflammatory cosmetic composition containing same |
| 09/19/2013 | WO2013137302A1 Lysine oligomer derivative and cartilage tissue marker made thereof |
| 09/19/2013 | WO2013109675A3 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 09/19/2013 | US20130244957 Methods for preventing or treating mitochondrial permeability transition |
| 09/19/2013 | US20130244945 Lissencephaly therapeutic agent |
| 09/19/2013 | US20130244944 Synthetic Ion Channels |
| 09/18/2013 | EP2638059A1 Dermatopontin-activating peptides and cosmetic compositions including same |
| 09/18/2013 | CN103304629A Preparation method of high-optical purity bortezomib and intermediate of bortezomib |
| 09/18/2013 | CN103304628A Nosiheptide derivatives and application thereof |
| 09/18/2013 | CN102399262B Tripeptides with angiotensin converting enzyme inhibition activity and their use and composition |
| 09/18/2013 | CN102382169B Argatroban single stereoisomer separation method and polymorph |
| 09/18/2013 | CN101652383B Hepatitis c virus inhibitors |
| 09/18/2013 | CN101228181B Hcv ns3蛋白酶抑制剂 Hcv ns3 protease inhibitors |
| 09/17/2013 | US8536303 Polypeptide inhibitors of HSP27 kinase and uses therefor |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8536122 Acylated GLP-1 compounds |
| 09/12/2013 | WO2013133032A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013133031A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013132317A1 Peptidomimetic compounds as immunomodulators |
| 09/12/2013 | US20130237483 Lipoyl Compounds And Their Use for Treating Ischemic Injury |
| 09/11/2013 | CN103298826A Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 09/11/2013 | CN103288918A Small peptide with dual inhibitory activity against renin and ACE, and applications thereof |
| 09/11/2013 | CN103288673A Platinum ligand and coordination compound thereof |
| 09/10/2013 | US8530623 Proteasome-activating lightening peptides and compositions containing same |
| 09/10/2013 | US8530622 Proteasome-activating anti-aging peptides and compositions containing same |
| 09/10/2013 | US8530620 Radiolabelling reagents and methods |
| 09/10/2013 | US8530441 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 09/10/2013 | US8530421 Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2562157C Processes for preparing eptifibatide |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/06/2013 | WO2013128003A1 N-terminally modified oligopeptides and uses thereof |
| 09/05/2013 | US20130231275 Aminiothiazoles and their uses |